What's Next for Advanced Melanoma?

Video

Jason Luke, MD, assistant professor at the University of Chicago Medicine, discusses what he hopes the future of advanced melanoma treatment will look like.

Jason Luke, MD, assistant professor at the University of Chicago Medicine, discusses what he hopes the future of advanced melanoma treatment will look like.

With new agents and combinations, long-term melanoma survival will continue to improve. Luke hopes that the future landscape for advanced melanoma -- and all cancers -- will become similar to managing a chronic disease. To do this, there must be treatments with high efficacy and low toxicity profiles.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
Photo of a woman with blonde hair wearing a denim jacket in front of a blue background
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a woman with brown hair and a floral blouse
Photo of a woman with a blue border around the image
2 experts are featured in this series.
2 experts are featured in this series.
Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop
Related Content
Green and pink model of a melanoma cell

NCCN Guidelines Update Includes HEPZATO KIT for Uveal Melanoma

Ashling Wahner
February 25th 2025
Article

Updates to the NCCN guidelines recommend HEPZATO KIT for use in hepatic-dominant uveal melanoma as a Category 2A treatment option.

The Vitals Podcast

Amber Pierce Underscores the Importance of 2-Step Verification With Relatlimab/Nivolumab

Lindsay Fischer
May 19th 2023
Podcast

Amber Pierce RN, BSN, OCN, highlights the importance of a 2-step verification process with fixed-dose regimen therapies.

dark blue background with a white outline indicating layers of skin

Cemiplimab as Adjuvant Therapy Improves DFS in High-Risk Cutaneous Squamous Cell Carcinoma

Caroline Seymour
January 20th 2025
Article

Adjuvant cemiplimab demonstrated a statistically significant improvement in DFS compared to placebo in post-surgical patients with high-risk CSCC, impacting post-operative care considerations.

the vitals

Krista Rubin Breaks Down Best Practices With Tebentafusp for Uveal Melanoma

Lindsay Fischer
May 4th 2023
Podcast

Krista M. Rubin, RN, MS, FNP-BC, highlights how nurses can help patients with uveal melanoma anticipate and manage adverse events during the step-up dosing period with tebentafusp.

FDA on clipboard

Accelerated Approval Sought for RP1-Nivolumab Combo for Pretreated Melanoma

Ashling Wahner
November 24th 2024
Article

The FDA received a biologics license application for accelerated approval of RP1 plus nivolumab for advanced, pretreated melanoma.

doctor in white coat holding hand out with the word "immunotherapy" floating above

Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers

Russ Conroy
November 12th 2024
Article

Adding E-602 to cemiplimab demonstrated anti-tumor effects in patients PD-L1–resistant solid cancers.